tiprankstipranks
Trending News
More News >
Valeo Pharma (VPHIF)
OTHER OTC:VPHIF
US Market

Valeo Pharma (VPHIF) Financial Statements

Compare
14 Followers

Valeo Pharma Financial Overview

Valeo Pharma's market cap is currently $3.15M. The company's EPS TTM is $; its P/E ratio is -0.18; Valeo Pharma is scheduled to report earnings on September 10, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Currency in CAD

Valeo Pharma Earnings and Revenue History

Valeo Pharma Debt to Assets

Valeo Pharma Cash Flow

Valeo Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.